Genomic study of the absorption mechanism of cantharidin and its solid dispersion

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 415, Issue , 2012, Pages 295-301

  Dang, Yun jie ^a   Zhu, Chun yan ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Caco 2 cell line; Cantharidin; Microarray; Solid dispersion

Indexed keywords

BIOCHEMISTRY; CELL CULTURE; CELLS; GENE EXPRESSION; MICROARRAYS; RATS;

ABSORPTION MECHANISMS; ABSORPTION RATES; ATP-BINDING CASSETTE; CACO-2 CELLS; CANTHARIDIN; CDNA MICROARRAYS; CELL LINES; DNA MICRO-ARRAY; GENETIC CHANGES; GENOMIC STUDIES; HOLISTIC EVALUATIONS; HUMAN INTESTINAL ABSORPTIONS; IN-VITRO; IN-VIVO; LIMITED INFORMATION; PERFUSION MODELS; RELATIVE BIOAVAILABILITY; SCREENING TECHNIQUES; SIMPLE METHOD; SOLID DISPERSION; SOLUTE CARRIERS;

DISPERSIONS;

ABC TRANSPORTER; CANTHARIDIN; COMPLEMENTARY DNA; MACROGOL 4000;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DISPERSION; DNA MICROARRAY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG PERITONEAL FLUID LEVEL; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84870278205     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2012.09.039     Document Type: Article

References (27)

1. National Pharmacopoeia Committee. Pharmacopoeia of Peoples Republic of China [M]. Part 1. Beijing: Chemical Industry Press (2010) 311-312.
2. Wang G.S. Medical uses of mylabris in ancient China and recent studies. J. Ethnopharmacol. 1989, 26:147-162.
3. Wang C.C., Wu C.H., et al. Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology 2000, 147:77-87.
4. Efferth T., Rauh R., et al. Molecular modes of action of cantharidin in tumor cells. Biochem. Pharmacol. 2005, 69:811-818.
5. Yunjie Dang C.Z. Determination of trace cantharidin in plasma and pharmacokinetic study in beagle dogs using gas chromatography-mass spectrometry. J. Anal. Toxicol. 2009, 33:227-231.
6. Kim E.J., Chun M.K., et al. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur. J. Pharm. Biopharm. 2006, 64:200-205.
7. Yamashita K., Nakate T., et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 2003, 267:79-91.
8. Joshi H.N., Tejwani R.W., et al. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. 2004, 269:251-258.
9. Vasconcelos T., Sarmento B., et al. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 2007, 12:1068-1075.
10. Dang Y.-J., Feng H.-Z., et al. In situ absorption in rat intestinal tract of solid dispersion of annonaceous acetogenins. Gastroenterol. Res. Pract. 2012, 1-9.
11. Dang Y.J., Hu C.H., et al. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000. Methods Find. Exp. Clin. Pharmacol. 2010, 32:157-162.
12. Barry Press D.D.G. Permeability for intestinal absorption: caco-2 assay and related issues. Curr. Drug Metab. 2008, 9:893-900.
13. Li A.P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today 2001, 6:357-366.
14. Dale O., Nilsen T., et al. Transepithelial transport of morphine and mannitol in Caco-2 cells: the influence of chitosans of different molecular weights and degrees of acetylation. J. Pharm. Pharmacol. 2006, 58:909-915.
15. Enslin G.M., Hamman J.H., et al. Intestinal drug absorption enhancers: synergistic effects of combinations. Drug Dev. Ind. Pharm. 2008, 34:1343-1349.
16. Wahlang B., Pawar Y.B., et al. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur. J. Pharm. Biopharm. 2011, 77:275-282.
17. Michael D. ATP, Binding Cassette (ABC) Transporter Supergene Family: Genetics and Evolution July 2008, John Wiley & Sons Ltd., Chichester. http://www.els.net/, 10.1002/9780470015902.a0006132.pub2.
18. Schlessinger A., Matsson P., et al. Comparison of human solute carriers. Protein Sci. 2010, 19:412-428.
19. Khan S., Elshaer A., et al. Systems biology approach to study permeability of paracetamol and its solid dispersion. Int. J. Pharm. 2011, 417:272-279.
20. Khan S., Elshaer A., et al. Genomic evaluation during permeability of indomethacin and its solid dispersion. J. Drug Target. 2011, 19:615-623.
21. Yang J.M., Ip S.P., et al. Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoprotein. PLoS ONE 2012, 7:e31312. 10.1371/journal.pone.0031312.
22. Zhang X.Y., Ke X., et al. Transport of limonin in rat intestine in situ and Caco-2 cells in vitro. Yao Xue Xue Bao 2012, 47:229-232.
23. Chang G. Multidrug resistance ABC transporters. FEBS Lett. 2003, 555:102-105.
24. Van der Pol M.A., Broxterman H.J., et al. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia. Haematologica 2003, 88:134-147.
25. Hugger E.D., Audus K.L., et al. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J. Pharm. Sci. 2002, 91:1980-1990.
26. Jones P.M., George A.M. Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. Int. J. Parasitol. 2005, 35:555-566.
27. Uldry M., Thorens B. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch. 2004, 447:480-489.